Member Info for MIKODX

Veuve.

PT

Goose - I actually prefer the Venue clicquot but as it's been such a special week I was going to splash out a bit. Might buy both and keep the Dom unopened for a couple of years lol.

It will be Dom Pérignon later on, for sure.

I had a good feeling the minute the tests were moved into the home environment. Logic told me they wouldn't have done that if they weren't having some success with the Hospital patients. I loaded up once that happened.

Closing on 2.0 would be good. What a week, best week of the year for me so far under difficult circumstances. Congratulations to all who held firmly for months and didn't cave in. You were richly rewarded. Hopefully we can kick on from here into the 4's and 5's which would really be something.

RNS Number : 4227T
Synairgen plc
27 July 2020

Southampton, UK - 20 July 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company which originated from research at the University of Southampton, are pleased to announce that due to the positive results from its clinical trial of SNG001, we have had enquiries from Brazil, USA, and India. We have agreed to deliver 1,000 Nebulisers for each country who will be conducting there own trials. If successful orders will be increased on an incremental basis. Synairgen are very pleased to have been able to secure these contracts.

About Synairgen

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.

Hopefully we get an RNS like this next week.

https://www.hindustantimes.com/india-news/maharashtra-to-start-rapid-antibody-tests-soon/story-cLKh5xMjUYXQGabYkwlt4J.html

Nothing around Mologic so far.

Thanks FS. I'll wait for now.

I'm thinking of jumping on here. Your thoughts for the future, do you think this is on the way up? Is this a good time to buy?

Thanks in advance.

If you or a relative are over 50 with other illnesses such as diabetes or heart/liver/kidney problems, and have recently tested positive for CV19, make sure to apply for the below.

http://www.covidtrialathome.com/

We've had good trade volumes this week. But a lot of that has been sells. I expect this to drop down further.

If we can just get that first order in, even if it's small, this will be a good start. We can then go after the US and other markets. But I doubt we will have to. If we grow in India that would be more than we could manage.

The Mologic test hasn't been officially rolled out anywhere yet, so yes I think they will trial them in small batches first.

My bad like I said. Just checked and I was actually getting this stock mixed up with another stock I hold. I have around seven or eight stocks I'm watching at the minute. Easily done.

Lol oilornothing.

My bad. It was 200m last time I looked. Didn't see the update.

ChrisToffer and strictlyinc, I think you guys are a bit confused. I suggest you talk to a broker.

149m is the amount of shares Synairgen are allowed to issue. Because that is their limit doesn't mean they're all sold. The MCAP is the SP multiplied by the total number of shares outstanding. This will be the number of shares the MM's have left to sell multiplied by the SP. This is why the MM's are asking for higher prices for the stock as there is only a limited supply left. Hence the high SP.

Our MCAP is now 200m. With only 149m shares issued the MM's will want top dollar for their stock. No wonder the SP is going up. If the demand continues this will sail North without news. Strong buy.

Slow trading day so far. If it doesn't pick up, I fully expect the SP to fall back by the end of play. The good news is we are now in the public eye, so any form of news will have this bouncing.